However, it was also reported that a high irisin level is associated with a higher risk of metabolic syndrome and cardiovascular disease, which could be the result of a compensatory increase in the secretion of irisin by muscle tissue and/or to overcome underlying irisin resistance in metabolically affected patients [10]. This evidence concerns the gene FNDC5 and cardiovascular disorder.